Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

EYPT EyePoint Pharmaceuticals Inc

8,26

0,23 (2,86%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more EyePoint Pharmaceuticals Charts.

News EyePoint Pharmaceuticals Inc

EyePoint to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dienstag 17 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Montag 16 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 4 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

EyePoint Announces First Patient Dosed in Second Global Phase 3 LUCIA Clinical Trial of DURAVYU™ for the Treatment of Wet Age-Related Macular Degeneration
Mittwoch 4 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Montag 18 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments
Donnerstag 7 November 2024 (2 Monate vor) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Montag 4 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 31 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

EyePoint Pharmaceuticals Announces Closing of Upsized Public Offering and Full Exercise of Option to Purchase Additional Shares
Donnerstag 31 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere EyePoint Pharmaceuticals Inc News-Artikel

Invesco QQQ Trust Series 1

Financial Select Sector

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen